A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data

Evolutionary Bioinformatics Online
Alicia Amadoz, Fernando González-Candelas

Abstract

The combined therapy of pegylated interferon (IFN) plus ribavirin (RBV) has been for a long time the standard treatment for patients infected with hepatitis C virus (HCV). In the case of genotype 1, only 38%-48% of patients have a positive response to the combined treatment. In previous studies, viral genetic information has been occasionally included as a predictor. Here, we consider viral genetic variation in addition to 11 clinical and 19 viral populations and evolutionary parameters to identify candidate baseline prognostic factors that could be involved in the treatment outcome. We obtained potential prognostic models for HCV subtypes la and lb in combination as well as separately. We also found that viral genetic information is relevant for the combined treatment assessment of patients, as the potential prognostic model of joint subtypes includes 9 viral-related variables out of 11. Our proposed methodology fully characterizes viral genetic information and finds a combination of positions that modulate inter-patient variability.

References

Mar 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S ZeuzemW K Roth
Dec 7, 2000·The New England Journal of Medicine·S ZeuzemM J Brunda
Dec 12, 2003·Bioinformatics·Julio RozasRicardo Rozas
Feb 11, 2004·International Journal of STD & AIDS·Anja M HauriYvan J F Hutin
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Neil Kaplowitz
Mar 5, 2004·Annals of Internal Medicine·Stephanos J HadziyannisUNKNOWN PEGASYS International Study Group
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bin GaoSvetlana Radaeva
Dec 4, 2004·Gastroenterology·Stefan ZeuzemUNKNOWN PEGASYS Study NR16071 Investigator Group
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·C Neumann-HaefelinR Thimme
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Wolf Peter HofmannChristoph Sarrazin
Feb 8, 2005·Journal of Clinical Microbiology·Catherine GaudyAlain Goudeau
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Jonathan ShepherdJohn Gabbay
Jun 17, 2005·The Journal of General Virology·Richard J P BrownJonathan K Ball
Sep 9, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter SimmondsAnders Widell
Dec 27, 2005·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Camille SzmaragdFrançois Balloux
Feb 25, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Lucy Golden-Mason, Hugo R Rosen
Dec 16, 2006·The Journal of General Virology·Nuria Jiménez-HernándezAndrés Moya
Jan 20, 2007·Nature Clinical Practice. Gastroenterology & Hepatology·Robert S Brown
Apr 24, 2007·BMC Infectious Diseases·Alicia Amadoz, Fernando González-Candelas
Nov 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Brian L PearlmanSophia Saifee
Dec 8, 2007·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Manuela Torres-PuenteFernando González-Candelas
Dec 22, 2007·Journal of Medical Virology·Manuela Torres-PuenteFernando González-Candelas
Feb 1, 2008·Journal of Viral Hepatitis·M Torres-PuenteF González-Candelas
Feb 19, 2008·Journal of Hepatology·Ariane MallatSophie Lotersztajn
Oct 18, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Haruaki ShirakawaUNKNOWN Nagano Interferon Treatment Research Group
Feb 25, 2009·Journal of Medical Virology·José M CuevasAndrés Moya

❮ Previous
Next ❯

Datasets Mentioned

BETA
D50481

Methods Mentioned

BETA
PCR

Software Mentioned

LASSObased
R
LASSO
DnaSP
SPSS
GLMNET

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.